BioSpace News Archive

Drug Development

Zymeworks Reports Preliminary Phase 1 Trial Results for Zanidatamab Zovodotin (ZW49) at European Society for Medical Oncology Annual Congress

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today presented preliminary results from the company’s Phase 1 clinical trial evaluating zanidatamab zovodotin (ZW49) for the treatment of HER2-positive tumors.

September 12, 2022
·
7 min read
MIMEDX EPIFIX® Receives Reimbursement Approval in Japan

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that the Japanese Ministry of Health, Labour and Welfare (JMHLW) approved reimbursement of EPIFIX® to treat refractory or hard-to-heal lower extremity diabetic and venous ulcers.

September 12, 2022
·
4 min read
Pharm Country

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MORGAN STANLEY’S 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE

Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at Morgan Stanley’s 20th Annual Global Healthcare Conference.

September 12, 2022
·
1 min read
Bio NC

United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit Report

United Therapeutics Corporation, a public benefit corporation, announced the release of its third annual Corporate Responsibility Report with 2021 highlights, providing stakeholders important information regarding the company’s commitment to environmental, social, and governance priorities.

September 12, 2022
·
4 min read
Genetown

Boston Heart Diagnostics Launches Polygenic Risk Scores Empowering the Next Generation of Clinical Genomics

Boston Heart Diagnostics is pleased to announce the availability of the Polygenic Risk Map™.

September 12, 2022
·
2 min read
Biotech Bay

AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

Amgen (NASDAQ:AMGN) will present at Bank of America Merrill Lynch’s 2022 Global Healthcare Conference at 4:55 a.m. ET on Thursday, Sept. 15, 2022.

September 12, 2022
·
2 min read
Cano Health to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Cano Health Inc. (“Cano” or the “Company”) (NYSE: CANO), a leading value-based primary care provider and population health company, today announced it will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022.

September 12, 2022
·
1 min read
InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 in China

InnoCare Pharma (HKEX: 09969) announced today that the Company has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical Products Administration) for its B-cell lymphoma-2 (BCL2) inhibitor ICP-248.

September 12, 2022
·
2 min read
BioMidwest

Revance Announces Pricing of $200.0 Million Upsized Public Offering of Common Stock

Revance Therapeutics, Inc., a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, announced the pricing of an upsized underwritten public offering of 8,000,000 shares of its common stock.

September 12, 2022
·
5 min read
Genetown

Relay Therapeutics Announces Pricing of Public Offering of Common Stock - September 13, 2022

Relay Therapeutics, Inc. announced the pricing of an underwritten public offering of 11,320,755 shares of its common stock at a public offering price of $26.50 per share.

September 12, 2022
·
4 min read